74
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

, , , , , , , & show all
Pages 479-491 | Published online: 26 Feb 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anthony D. D’Urzo, Dave Singh, James F. Donohue, Kenneth R. Chapman & Robert A. Wise. (2021) Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update. Expert Review of Respiratory Medicine 15:9, pages 1093-1106.
Read now
Donald P Tashkin. (2020) Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3105-3122.
Read now

Articles from other publishers (3)

Paola Rogliani, Francesco Cavalli, Beatrice Ludovica Ritondo, Mario Cazzola & Luigino Calzetta. (2022) Sex differences in adult asthma and COPD therapy: a systematic review. Respiratory Research 23:1.
Crossref
Kaiwen Ni, Jia Yang, Huan Yang, Shiming Zhu & Zhen Wang. (2022) RETRACTED: Comparison of efficacy and side effects of Fixed-dose combination of Aclidinium/Formoterol and Monotherapy of Aclidinium or Formoterol in COPD: A meta-analysis. Heart & Lung 51, pages 25-31.
Crossref
Claire C. Eng & Mojdeh S. Heavner. (2021) Pharmacology Considerations in Women in Lung Disease and Critical Care. Clinics in Chest Medicine 42:3, pages 557-566.
Crossref